Found 75 matching trials
Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan PHASE1 This clinical lactation study is to provide information regarding the PK an...
Show More Location
Alkermes Investigator Site
Learn More & Join Trial
Melatonin for Prevention of Metabolic Side Effects of Olanzapine PHASE2 The purpose of this study is to determine whether melatonin can prevent met...
Show More Location
Shafa Psychiatric Hospital
Learn More & Join Trial
Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV PHASE3 Chemotherapy-induced nausea and vomiting is a common side effect of cancer ...
Show More Location
Fifth Affilliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Enhancing Recovery in Early Schizophrenia PHASE2 Current antipsychotic treatments of schizophrenia are only partially effect...
Show More Status
Active Not Recruiting
Location
Dep. of Psychiatry and Psychotherapy, Central Institute of Mental Health
Learn More & Join Trial
A Study of ALKS 3831 in Adults With Schizophrenia PHASE2 This is a Phase 2, randomized, placebo-controlled multicenter study, which ...
Show More Location
Alkermes Investigational Site
Learn More & Join Trial
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder PHASE2 This double-blind, randomized study will evaluate the efficacy, safety and ...
Show More Location
Alkermes Investigational Site
Learn More & Join Trial
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients PHASE3 The objective of this study is to investigate the efficacy of olanzapine as...
Show More Location
University of Michigan Rogel Cancer Center
Learn More & Join Trial
Olanzapine in Patients With Advanced Cancer and Weight Loss PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study PHASE3 This is a multicenter, randomized, controlled, double-blind, phase III stud...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy PHASE3 This randomized phase III trial studies how well olanzapine with or without...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial